Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced today that the Company will withdraw its European Marketing Authorization Application (MAA) for vosaroxin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE